136 related articles for article (PubMed ID: 9103527)
21. Interactive nitric oxide-angiotensin II influences on renal microcirculation in angiotensin II-induced hypertension.
Ichihara A; Imig JD; Inscho EW; Navar LG
Hypertension; 1998 Jun; 31(6):1255-60. PubMed ID: 9622138
[TBL] [Abstract][Full Text] [Related]
22. Effect of angiotensin-converting enzyme two-week inhibition on renal angiotensin II receptors and renal vascular reactivity in SHR.
Haddad G; Garcia R
J Mol Cell Cardiol; 1997 Feb; 29(2):813-22. PubMed ID: 9140837
[TBL] [Abstract][Full Text] [Related]
23. Escherichia coli bacteremia exacerbates cyclosporine-induced renal vasoconstriction.
Bloom IT; Bentley FR; Garrison RN
J Surg Res; 1993 May; 54(5):510-6. PubMed ID: 8361177
[TBL] [Abstract][Full Text] [Related]
24. Angiotensin II sensitivity of afferent glomerular arterioles in endothelin-1 transgenic mice.
Patzak A; Bontscho J; Lai E; Kupsch E; Skalweit A; Richter CM; Zimmermann M; Thöne-Reineke C; Joehren O; Godes M; Steege A; Hocher B
Nephrol Dial Transplant; 2005 Dec; 20(12):2681-9. PubMed ID: 16188896
[TBL] [Abstract][Full Text] [Related]
25. Cellular mechanism for mibefradil-induced vasodilation of renal microcirculation: studies in the isolated perfused hydronephrotic kidney.
Hayashi K; Ozawa Y; Wakino S; Kanda T; Homma K; Takamatsu I; Tatematsu S; Saruta T
J Cardiovasc Pharmacol; 2003 Dec; 42(6):697-702. PubMed ID: 14639089
[TBL] [Abstract][Full Text] [Related]
26. Effects of captopril, losartan, and nifedipine on cell hypertrophy of cultured vascular smooth muscle from hypertensive Ren-2 transgenic rats.
Peiró C; Llergo JL; Angulo J; López-Novoa JM; Rodríguez-López A; Rodríguez-Mañas L; Sánchez-Ferrer CF
Br J Pharmacol; 1997 Aug; 121(7):1438-44. PubMed ID: 9257925
[TBL] [Abstract][Full Text] [Related]
27. Afferent and efferent arteriolar vasoconstriction to angiotensin II and norepinephrine involves release of Ca2+ from intracellular stores.
Inscho EW; Imig JD; Cook AK
Hypertension; 1997 Jan; 29(1 Pt 2):222-7. PubMed ID: 9039106
[TBL] [Abstract][Full Text] [Related]
28. Role of angiotensin II generated by angiotensin converting enzyme-independent pathways in canine kidney.
Murakami M; Matsuda H; Kubota E; Wakino S; Honda M; Hayashi K; Saruta T
Kidney Int Suppl; 1997 Dec; 63():S132-5. PubMed ID: 9407441
[TBL] [Abstract][Full Text] [Related]
29. Reduced renal microvascular reactivity to angiotensin II in diabetic rats.
Inman SR; Porter JP; Fleming JT
Microcirculation; 1994 Jul; 1(2):137-45. PubMed ID: 8790585
[TBL] [Abstract][Full Text] [Related]
30. Renal afferent and efferent arteriolar dilation by nilvadipine: studies in the isolated perfused hydronephrotic kidney.
Ozawa Y; Hayashi K; Nagahama T; Fujiwara K; Wakino S; Saruta T
J Cardiovasc Pharmacol; 1999 Feb; 33(2):243-7. PubMed ID: 10028932
[TBL] [Abstract][Full Text] [Related]
31. Mechanical activation of angiotensin II type 1 receptors causes actin remodelling and myogenic responsiveness in skeletal muscle arterioles.
Hong K; Zhao G; Hong Z; Sun Z; Yang Y; Clifford PS; Davis MJ; Meininger GA; Hill MA
J Physiol; 2016 Dec; 594(23):7027-7047. PubMed ID: 27531064
[TBL] [Abstract][Full Text] [Related]
32. Altered renal microvascular response in Zucker obese rats.
Hayashi K; Kanda T; Homma K; Tokuyama H; Okubo K; Takamatsu I; Tatematsu S; Kumagai H; Saruta T
Metabolism; 2002 Dec; 51(12):1553-61. PubMed ID: 12489067
[TBL] [Abstract][Full Text] [Related]
33. Membrane potential measurements in renal afferent and efferent arterioles: actions of angiotensin II.
Loutzenhiser R; Chilton L; Trottier G
Am J Physiol; 1997 Aug; 273(2 Pt 2):F307-14. PubMed ID: 9277592
[TBL] [Abstract][Full Text] [Related]
34. Function of angiotensin II type 2 receptor in the postglomerular efferent arteriole.
Endo Y; Arima S; Yaoita H; Omata K; Tsunoda K; Takeuchi K; Abe K; Ito S
Kidney Int Suppl; 1997 Dec; 63():S205-7. PubMed ID: 9407460
[TBL] [Abstract][Full Text] [Related]
35. Neuronal nitric oxide synthase modulates rat renal microvascular function.
Ichihara A; Inscho EW; Imig JD; Navar LG
Am J Physiol; 1998 Mar; 274(3):F516-24. PubMed ID: 9530268
[TBL] [Abstract][Full Text] [Related]
36. Disparate effects of calcium antagonists on renal microcirculation.
Hayashi K; Nagahama T; Oka K; Epstein M; Saruta T
Hypertens Res; 1996 Mar; 19(1):31-6. PubMed ID: 8829821
[TBL] [Abstract][Full Text] [Related]
37. Reduced reactivity of renal microvessels to pressure and angiotensin II in fawn-hooded rats.
van Rodijnen WF; van Lambalgen TA; Tangelder GJ; van Dokkum RP; Provoost AP; ter Wee PM
Hypertension; 2002 Jan; 39(1):111-5. PubMed ID: 11799088
[TBL] [Abstract][Full Text] [Related]
38. Effects of insulin on rat renal microvessels: studies in the isolated perfused hydronephrotic kidney.
Hayashi K; Fujiwara K; Oka K; Nagahama T; Matsuda H; Saruta T
Kidney Int; 1997 May; 51(5):1507-13. PubMed ID: 9150466
[TBL] [Abstract][Full Text] [Related]
39. Characterization of the renal microvascular actions of a new dopaminergic (DA1) agonist, YM435.
Takenaka T; Forster H; Epstein M
J Pharmacol Exp Ther; 1993 Mar; 264(3):1154-9. PubMed ID: 8095547
[TBL] [Abstract][Full Text] [Related]
40. Iodinated contrast media differentially affect afferent and efferent arteriolar tone and reactivity in mice: a possible explanation for reduced glomerular filtration rate.
Liu ZZ; Viegas VU; Perlewitz A; Lai EY; Persson PB; Patzak A; Sendeski MM
Radiology; 2012 Dec; 265(3):762-71. PubMed ID: 23023964
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
